MAIA Biotechnology, Inc.
MAIA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001878313
In the last 90 days, MAIA Biotechnology, Inc. insiders filed 5 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $19.4M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding MAIA Biotechnology, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 21 | 1 | 17 | −3 |
| Shares | 1.79M | 78.5K | 1.47M | −242.3K (−14.2%) |
| Value | $6.09M | $268.5K | $4.15M | −$1.68M (−28.8%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held MAIA Biotechnology, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 79,727 | $224.0K | 0.00% |
| UBS Group AG | 16,685 | $46.9K | 0.00% |
| XTX Topco Ltd | 10,991 | $30.9K | 0.00% |
Sold out (6)
Institutions that held MAIA Biotechnology, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Ground Swell Capital, LLC | 16,460 | $56.3K |
| Verition Fund Management LLC | 15,372 | $52.6K |
| Jane Street Group, LLC | 11,930 | $40.8K |
| Omers Administration Corp | 10,800 | $36.9K |
| Mather Group, LLC. | 12,060 | $26.5K |
| Royal Bank of Canada | 86 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held MAIA Biotechnology, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 78,521 | $268.5K |